BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, April 24, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

March 18, 2004

View Archived Issues

Targeting telomerase for multiple myeloma therapy

Read More

Phase I pilot trial of L612 HuMAb in metastatic melanoma

Read More

Array BioPharma signs for use of CyDex's Captisol

Read More

TopoTarget and deCODE collaborate on improved cancer treatments

Read More

Series B financing to fund development of BioRexis' biopharmaceuticals

Read More

SurroMed and Biogen Idec extend collaborative research agreement

Read More

Xenova focuses on highest potential clinical stage programs

Read More

Aprepitant enhances the efficacy of standard antiemetics for chemotherapy patients

Read More

Aloxi incorporated in NCCN antiemetic guidelines for CINV

Read More

Promising candidate for treatment of acute stroke

Read More

ChemoCentryx and Forest collaborate on chemokine-based therapeutics

Read More

New inhibitors of VEGFR2 and FGFR1 identified by BMS scientists

Read More

Argenta describes new HDAC inhibitors and their use in cancer and other disorders

Read More

AstraZeneca team prepares and tests new Tie-2 inhibitors

Read More

Novel antiinflammatory erythromycins devoid of antibiotic activity claimed by Zambon

Read More

Bayer scientists design novel alpha7 nAchR agonists

Read More

Three related series of chemokine CCR5 modulators reported by GSK

Read More

Protective effects of pexelizumab in AMI patients

Read More

Avasimibe prevents plaque progression in patients with coronary atherosclerosis

Read More

Good safety profile of CVT-3146 in myocardial perfusion imaging

Read More

ED-71 increases bone formation and reduces bone resorption after bone marrow ablation in mice

Read More

TP-508 promotes fracture healing in rats via enhancement of immune responses

Read More

Antisense GHR inhibitor shows promise in animal studies

Read More

Crucell and NeoTropiX enter PER.C6 technology licensing agreement

Read More

Cypher sirolimus-eluting stent one step away from Japanese approval

Read More

Raptiva receives Swiss approval

Read More

Enrollment completed in phase III traumatic brain injury study of dexanabinol

Read More

Novo Nordisk obtains North American rights to IL-20

Read More

Panacos studies HIV maturation inhibitor in phase I trial

Read More

A-HeFT trial of BiDil cleared to continue by DSMB

Read More

Zydus Cadila launches Nucoxia in India

Read More

FGF-18 promotes cartilage repair in a rat model of injury-induced osteoarthritis

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 23, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 21, 2026
  • Green arrow on blue abstract background

    Psychedelic space expanding on Trump’s EO

    BioWorld
    Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
  • Illustration of metastatic cancer

    At AACR: Epigenetic fingerprints in metastases track tumor origin

    BioWorld
    When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
  • Illustration of human face that looks abstract and digital

    AACR 2026: The age of agentic AI in oncology

    BioWorld Science
    New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing